How to Combine DDA and DIA for Deep Proteome Coverage?

    In proteomics research, achieving deeper proteome coverage has consistently been a central objective. With advances in mass spectrometry technologies, Data-Dependent Acquisition (DDA) and Data-Independent Acquisition (DIA) have become the dominant strategies, each offering distinct technical strengths. In recent years, hybrid approaches that combine DDA and DIA have increasingly been regarded as effective solutions for improving both identification depth and quantitative accuracy.

    DDA and DIA: Advantages and Limitations

    1. Data-Dependent Acquisition (DDA)

    DDA remains the most widely adopted method in conventional proteomics experiments. In the DDA mode, the mass spectrometer first performs an MS1 survey scan to select the most intense precursor ions (typically the top 10–20), followed by MS/MS fragmentation.

    (1) Advantages

    • The resulting MS/MS spectra are generally of high quality, supporting confident peptide identification.

    • DDA data play an essential role in the construction of high-quality spectral libraries.

    (2) Limitations

    • The method preferentially selects high-abundance proteins, while low-abundance species may be undersampled.

    • Data reproducibility is relatively limited, and identification bias can occur across different batches.

    2. Data-Independent Acquisition (DIA)

    DIA represents a more comprehensive acquisition strategy. It partitions the entire m/z range into multiple isolation windows and fragments all ions within each window simultaneously, thereby minimizing selection bias.

    (1) Advantages

    • Quantitative measurements are highly reproducible, making the method well suited for large cohort studies.

    • It enables improved detection of low-abundance proteins, providing a more extensive representation of the proteome.

    (2) Limitations

    • The raw datasets are highly complex and depend on high-quality spectral libraries for accurate deconvolution and identification.

    • The analytical requirements are demanding and rely on specialized software platforms and computational infrastructure.

    Hybrid Strategy: Synergy Between DDA and DIA

    The combination of DDA and DIA typically involves first generating an experimental spectral library using DDA, followed by DIA-based quantification using this reference. This workflow has been demonstrated in numerous studies to markedly enhance proteome coverage and overall data reliability.

    1. Library Construction Using DDA to Establish a Robust Identification Framework

    By performing highly replicated DDA measurements, often together with sample pre-enrichment or fractionation strategies, high-quality peptide MS/MS spectra can be collected to build sample-specific reference spectral libraries. This step defines the baseline capability of subsequent DIA data interpretation.

     

    2. Leveraging DIA for High-Throughput and Reproducible Quantification

    With a well-curated spectral library serving as a reference, DIA enables quantitative profiling with broad coverage and low missing value rates in complex biological samples. This approach is particularly advantageous in studies involving strong tissue heterogeneity, large sample cohorts, or the analysis of low-abundance proteins.

    MtoZ Biolabs: An Integrated High-Quality DDA + DIA Solution

    At MtoZ Biolabs, DDA and DIA are strategically integrated to provide the following service strengths:

    • Customized DDA library construction: fractionation schemes are designed according to project characteristics to maximize spectral depth.

    • Standardized DIA acquisition workflows: high-resolution mass spectrometry platforms, including Orbitrap Exploris 480, are employed to ensure data robustness.

    • Comprehensive data analysis support: widely adopted software systems such as Spectronaut and DIA-NN are applied in parallel, enabling the delivery of traceable and reproducible quantitative proteomics results.

    For both fundamental research and translational investigations, MtoZ Biolabs focuses on delivering proteomics datasets with extensive coverage and high sensitivity, thereby supporting scientific exploration and downstream applications.

    Through the rational integration of DDA and DIA methodologies, researchers can obtain more complete qualitative characterization of the proteome while achieving substantial improvements in quantitative accuracy and reproducibility. As mass spectrometry instrumentation and computational algorithms continue to evolve, combined DDA + DIA strategies are expected to demonstrate increasing value in the study of complex biological systems. Drawing on years of experience in mass spectrometry operations and life science research, MtoZ Biolabs provides end-to-end, integrated services spanning experimental design to final data delivery, with particular expertise in DDA + DIA hybrid workflows.

    MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

    Related Services

Submit Inquiry
Name *
Email Address *
Phone Number
Inquiry Project
Project Description *

 

How to order?


How to order

Submit Your Request Now ×
/assets/images/icon/icon-message.png

Submit Inquiry

/assets/images/icon/icon-return.png